Advertisement

Topics

Latest "Cardiovascular Consultants, Ltd." News Stories

01:12 EDT 21st May 2018 | BioPortfolio

Here are the most relevant search results for "Cardiovascular Consultants, Ltd." found in our extensive news archives from over 250 global news sources.

More Information about Cardiovascular Consultants, Ltd. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Cardiovascular Consultants, Ltd. for you to read. Along with our medical data and news we also list Cardiovascular Consultants, Ltd. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Cardiovascular Consultants, Ltd. Companies for you to search.

Showing "Cardiovascular Consultants" News Articles 1–25 of 2,500+

Saturday 19th May 2018

XBiotech Inc XBIT Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 19032018] Prices from USD $250

SummaryXBiotech Inc XBiotech is a bioscience company that discovers and develops True Human monoclonal antibodies the company provides monoclonal antibodies treatment for various diseases. It's lead product Xilonix, a therapeutic antibody being developed for the treatment of metastatic colorectal cancer. The company offers clinical trial activity services, oncology, MRSA, cardiovascular disease, d...


Cardiovascular Mortality Rates Vary Among VA Hospitals (CME/CE)

(MedPage Today) -- Results point to care differences

Friday 18th May 2018

[Comment] Diabetes mortality in the USA: winning the battle but not the war?

A worldwide epidemic of type 2 diabetes is underway. In 2017, the International Diabetes Federation estimated that 425 million people had diabetes globally, an increase of 274 million since 2000, and that 4 million excess deaths were attributable to diabetes, compared with about 2 million in 2000.1,2 Death rates in people with diabetes are higher than in people of similar sex and age without diabe...


LOKELMATM Approved in the US for the Treatment of Adults with Hyperkalemia

LOKELMA provides a rapid and sustained treatment for hyperkalemia, a condition with high unmet need1,2,3,4 AstraZeneca (NYSE: AZN) today announced that the US Food and Drug Administration (FDA) has approved LOKELMATM (sodium zirconium cyclosilicate), formerly ZS-9, for the treatment of hyperkalemia in

Natural antioxidant bilirubin may provide cardiovascular benefits

Bilirubin, a yellow-orange pigment, is formed after the breakdown of red blood cells and is eliminated by the liver. It's not only a sign of a bruise, it may provide cardiovascular benefits, according to a large-scale epidemiology study.

Serum 25-hydroxyvitamin D and cardiovascular disease risk factors in women with excessive weight gain during pregnancy and in their offspring at age 5–6 years

HAEMATO AG - IFRS Results Q1 2018

DGAP-News: HAEMATO AG / Key word(s): Quarterly / Interim Statement/Quarter Results 18.05.2018 / 13:10 The issuer is solely responsible for the content of this announcement. HAEMATO AG - IFRS Results Q1 2018   HAEMATO AG is a listed pharmaceutical company focusing on the growth markets of high-priced special pharmaceuticals from the indication areas oncology and HIV as well as in t...

Risk After Afib Resolves; Vein Graft Failure; Lytics for Wake-Up Strokes

(MedPage Today) -- Cardiovascular Daily wraps up the top cardiology news of the week

Alendronate Reduces Cardiovascular Risk After Hip Fracture

Alendronate, and likely other bisphosphonates, lower cardiovascular event rates in patients treated for osteoporosis following a hip fracture. Medscape Medical News

Royal Philips, AHA, UPMC establish venture fund targeting cardiovascular treatment innovations

The American Heart Association (AHA), along with Royal Philips and UPMC, has announced the launch of Cardeation Capital, a $30m collaborative venture capital fund designed to spur healthcare innovation in heart disease and stroke care.

High risk heart patients should be warned when cold weather on way

Smartphone messages should be sent to high risk cardiovascular patients when adverse weather conditions are predicted, say researchers, who found heart attacks were more common during cold snaps.

Osteoporosis drug alendronate may be good for the heart

An osteoporosis drug called alendronate has been linked with a reduced risk of cardiovascular death, heart attack and stroke in research published in the Journal of Bone and Mineral Research. Data from nearly 35,000 people newly diagnosed with hip fracture was assessed. A total of 4,602 of the volunteers received osteoporosis treatment during follow-up. The […] The post Osteoporosis drug ale...

Thursday 17th May 2018

Study: Acute kidney injury linked with higher risk of cardiovascular events post hospital discharge

Acute kidney injury (AKI), an abrupt or rapid decline in kidney function, is an increasingly prevalent and potentially serious condition that often arises due to medical conditions or treatments that may deprive the kidneys of a normal blood flow or damage kidney tissue.

Natural antioxidant bilirubin may improve cardiovascular health

(Emory Health Sciences) A recent analysis of health data from almost 100,000 veterans, both with and without HIV infection, found that within normal ranges, higher levels of bilirubin in the blood were associated with lower rates of heart failure, heart attack and stroke.

Humira does not improve aortic vascular inflammation in psoriasis patients

(University of Pennsylvania School of Medicine) An antibody used to treat the skin disease psoriasis and other chronic autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease has no effect on aortic inflammation -- a key marker of future risk of major cardiovascular events -- unlike other antibodies that target different aspects of the immune system.

Combination of wearables, AI may help ID onset of cardiovascular disease

Combination of wearables, AI may help ID onset of cardiovascular disease sthakar Thu, 05/17/2018 - 21:03 Teaser Media

Acute Kidney Injury in Hospital Ups Risk of Later Heart Failure

THURSDAY, May 17, 2018 -- Acute kidney injury (AKI) is independently associated with a higher risk of cardiovascular events, especially heart failure, after hospital discharge, according to a study published online May 17 in the Clinical Journal of...

Philips, AHA & UPMC Launch $30M Fund to Spur Health Innovation in Heart Disease and Stroke Care

Philips, American Heart Association (AHA) and UPMC’s announcement to launch Cardeation Capital, a new $30 million venture fund designed to spur healthcare innovation in heart disease and stroke care. With cardiovascular disease costs projected to exceed $1 trillion by 2035, this initiative will play a critical role in transforming care for a healthier, less costly ... Read More

UVA LVG Seed Fund Invests in 510 Kardiac Devices

The University of Virginia Licensing & Ventures Group (LVG) Seed Fund announced its fourth investment, 510 Kardiac Devices, Inc. (510 Kardiac). 510 Kardiac is an early stage medical device company developing novel technologies for cardiovascular surgical procedures. The investment will accelerate the company's efforts to obtain FDA approval for the Lim Transseptal System (LTS), a surgical in...

Group general counsel for Novartis takes personal responsibility for Cohen payments and steps down

The group general counsel of Swiss pharma company, Novartis, has stepped down from his role, taking personal responsibility for what he has described as the ‘erroneous’ agreement made with Essential Consultants, which is owned by Michael Cohen

CellAegis Announces Completion of Patient Enrollment in Danish Investigator Sponsored Clinical Trial Using autoRIC® Device

TORONTO, May 17, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. ("CellAegis" or the "Company"), a commercial-stage medical device company advancing innovative, non-invasive, safe and cost-effective solutions for acute and chronic cardiovascular conditions, today announced completion of patient enrollment in a large scale, investigator sponsored trial ("CONDI 2"...

On World Hypertension Day, make sure the silent killer doesn’t strike you – Independent Online

Independent OnlineOn World Hypertension Day, make sure the silent killer doesn't strike youIndependent OnlineDurban - Today, Thursday, is World Hypertension Day, and doctors around South Africa are urging people to test regularly for this the 'silent killer' that can show no signs or symptoms, but can lead to serious cardiovascular disease. Last year an ...World Hypertension Day: Not just the hear...

National Academy of Medicine President to Deliver 2018 Commencement Address for Ross University School of Medicine

Ross University School of Medicine (RUSM) announced today that Dr. Victor J. Dzau, President of the National Academy of Medicine (NAM), will serve as the 2018 inaugural Honorary Degree recipient and keynote speaker. “We are extremely honored to have Dr. Dzau participate in our commencement ceremony,” said Dr. William F. Owen, Jr., MD, FACP, RU...

Seafood Recommended 1 to 2 Times/Week for Cardiac Benefit

THURSDAY, May 17, 2018 -- One to two servings of seafood per week is recommended for cardiovascular benefits, according to an American Heart Association science advisory published online May 17 in Circulation. Eric B. Rimm, Sc.D., from the Harvard...

Cardiovascular Disease Risk Varies by Birth Month in Canines


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks